WUXI BIO(02269.HK) will spend HKD 99.82 million to repurchase 3.04 million shares on Jun 5, 2026
WUXI BIO(02269.HK) released an announcement on Jun 5, 2026, stating that on Jun 5, 2026 it will spend HKD 99.82 million to repurchase 3.04 million shares, repurchase price per share is HKD 32.52 - HKD 33.8.
NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- HANSOH's ADC Licensing Deal with Roche Worth up to USD 15 Billion and a Record Share of Chinese Studies at ESMO LBA; CSOP Hang Seng Biotech ETF (03174.HK) Rises 2.09% Against the Trend on 20 October
- Biotech Index Hits a Year-to-Date High as Innovative Drug and CXO Names Rally; CSOP Hang Seng Biotech ETF (3174.HK) Gains 3.18% and Is Up 17.93% Year-to-Date
- WUXI BIO(02269.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 2.44 billion, YoY increase of 4.3%
- WUXI BIO(02269.HK) will spend HKD 49.24 million to repurchase 1.6 million shares on Jun 22, 2026
- WUXI BIO(02269.HK) will spend HKD 49.89 million to repurchase 1.51 million shares on Jun 3, 2026
